$6.95 0.21 (+3.12%)
11/20/2009 4:00 PM

POZEN, Inc. (POZN)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing products which can provide improved efficacy, safety or patient convenience in the treatment of acute and chronic pain and pain related conditions.

Current Price $6.95 Mkt Cap $207.29M
Open $6.72 P/E Ratio 15.68
Prev. Close $6.74 Div. (Yield) N/A (N/A)
Daily Range $6.50 - $6.99 Volume 222,992
52-Wk Range $4.50 - $8.42 Avg. Daily Vol. 96,000

POZN News and Commentary

Caps

How do you think POZN will perform vs the S&P 500?

Add Stock to Watchlist

All Members

103 Outperform
26 Underperform
 

All-Star Members

17 Outperform
8 Underperform
 

Wall Street

5 Outperform
2 Underperform
 

Top POZN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

everclear08 (< 20)
Submitted March 14, 2008

FDA concerns about tox have been addressed according to publicly available data. Given that the concern was addressed and seemingly negated, it would seem approval is right around the corner.

Word of Caution: You can never predict how the… More

0 Comments | Reply | Report this Post

zzlangerhans (99.51)
Submitted January 28, 2009

Pozen has been poisonous to virtually anyone who has gone long in it the last couple of years. The main problem is Treximet, the groundbreaking new migraine medication that combines sumatriptan with naproxen. Oh wait, that's pretty much the same… More

0 Comments | Reply | Report this Post
POZN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about POZN.

Recs

0
Member Avatar philsie2 (< 20) Submitted: 12/8/2008 12:06:05 AM : Outperform Start Price: $6.32 POZN Score: -14.30

If FDA accepts the gastric ulcer endpoint for PN400 and the PA program then we'll see a very strong move back to the $12-15. Add to that a very good acceptance, so far, of Treximet there are a lots of positives in the making. Excellent time to take advantage of a good entry; though right now that's true of just about anything.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar markwusinich (< 20) Submitted: 8/20/2008 8:55:57 AM : Outperform Start Price: $11.84 POZN Score: -29.95

Top 20 Naked Put Trades

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar philsie1 (< 20) Submitted: 7/7/2008 1:33:56 PM : Outperform Start Price: $9.61 POZN Score: -18.54

Undervalued per earnings potential of Treximet and pipeline including PN and PA. Many catalysts coming in next couple months, sales data on Treximet, partner for PA and SPA acceptance. PN data later in year or early next year.

Report this Post 0 Comments | Reply | Permalink
View All 23 Pitches »

Leaderboard

Find the members with the highest scoring picks in POZN.

Score Leader

TMFBreakerCharly

TMFBreakerCharly (99.07) Score: +66.14

The Score Leader is the member with the highest score across all their picks in POZN.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
vedawg < 20 11/8/2006 Underperform 3Y $15.92 -56.34% -15.69% +40.66
NewbieMcNewbers < 20 1/19/2007 Underperform NS $17.06 -59.26% -18.74% +40.52 1 Comment
CraigMiles < 20 1/30/2009 Underperform 1Y $7.38 -5.83% +34.08% +39.91
jarhead6266 86.35 7/18/2007 Underperform NS $19.50 -64.36% -25.31% +39.05
mbriggs69 53.96 10/20/2006 Underperform 3W $14.89 -53.32% -15.00% +38.33
krazyaznman 50.26 1/29/2009 Underperform 1Y $7.49 -7.21% +30.53% +37.74
luiginavarro < 20 2/6/2009 Underperform 3M $7.28 -4.53% +31.23% +35.76
kevleeyang 73.42 1/30/2009 Underperform 5Y $7.21 -3.61% +31.05% +34.66
JimAnt 36.30 4/26/2007 Underperform 5Y $15.50 -55.16% -22.60% +32.56 1 Comment
ahknaten 80.24 7/13/2009 Underperform 5Y $7.54 -7.82% +24.51% +32.33
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackBreanMurray 87.51 9/23/2009 Outperform NS $7.23 -3.87% +1.97% -5.84
TrackZacks 70.74 1/29/2009 Outperform 3M $7.47 -6.96% +27.29% -34.25 1 Comment
TrackJefferies 31.78 10/20/2008 Underperform NS $6.63 +4.83% +17.63% +12.81
TrackJimCramer 36.31 5/5/2008 Underperform 3W $14.07 -50.60% -19.42% +31.19
TrackZacks 70.74 1/16/2008 Outperform 3M $12.76 -51.49% -27.87% -23.62 10/20/2008 @ $6.19 1 Comment
TrackMorganJos < 20 5/31/2007 Outperform NS $15.91 -56.32% -24.71% -31.61
TrackJimCramer 36.31 4/25/2007 Outperform 3W $14.99 -6.14% -5.79% -0.35 5/6/2008 @ $14.07
TrackCitigroup < 20 4/20/2007 Outperform NS $14.75 -55.05% -36.02% -19.03 10/20/2008 @ $6.63
TrackRWBaird 81.68 12/29/2006 Outperform NS $18.02 -61.43% -18.23% -43.20
TrackLazardCapit < 20 12/8/2006 Outperform NS $16.89 -43.69% +4.39% -48.08 8/3/2007 @ $9.51
TrackSusquehanna 73.96 11/21/2006 Outperform NS $16.50 -21.21% -1.39% -19.82 4/18/2008 @ $13.00
TrackRBCCapMkts 82.07 11/1/2006 Outperform NS $16.70 -58.38% -15.97% -42.42
TrackBroadpoint.AmTech 71.55 11/1/2006 Underperform NS $16.70 -23.53% +0.22% +23.75 4/21/2008 @ $12.77
TrackJimCramer 36.31 4/21/2006 Underperform 3W $15.91 -5.78% +13.52% +19.31 4/25/2007 @ $14.99

Featured Broker Partners